Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple Sclerosis

Research Site, Chiba

Research Site, Fukuoka

Research Site, Hiroshima

Research Site, Sapporo

Research Site, Sapporo

Research Site, Tsukuba

Research Site, Morioka

Research Site, Yokohama

Research Site, Kyoto

Research Site, Kyoto

Research Site, Kyoto

Research Site, Sendai

Research Site, Niigata

Research Site, Osaka

Research Site, Suita

Research Site, Kawagoe

Research Site, Tokorozawa

Research Site, Bunkyo-ku

Research Site, Bunkyo-ku

Research Site, Kodaira

Research Site, Ōta-ku

Research Site, Ube